MuskogeePhoenix.com, Muskogee, OK

April 27, 2013

FDA raid of Tulsa cancer center sought unapproved drug


Associated Press

— TULSA (AP) — U.S. Food and Drug Administration agents who raided a Tulsa cancer clinic were looking for an unapproved drug that was advertised by the center as a treatment for cancer, according to the application for the search warrant.

Agents raided Camelot Cancer Care on Tuesday, seizing seized computers, cellphones, bills, patient files, tax returns and invoices, apparently including an invoice for the drug laetrile, according to documents.

The Tulsa World reported Saturday that the documents say Camelot owner Maureen Long and employees fraudulently advertised laetrile as a cure for cancer. The search warrant application says laetrile has not been proven effective in treating cancer but has been shown to cause symptoms of cyanide poisoning.

Long told the newspaper that she can’t defend herself and referred questions to her lawyer, who did not return phone calls.

The FDA said it began investigating the clinic in March 2011 after receiving a complaint that it was using laetrile, using an undercover agent who visited the clinic representing himself as a person looking for treatment for a spouse.

According to the document, Long said the clinic received the drug from a Mexican manufacturer. It alleges that Long violated the law by “causing an unapproved new drug to be introduced or delivered for introduction into interstate commerce.”

She told the agent she hoped he wasn’t recording their conversation because she could be arrested and prosecuted for the services provided at Camelot, the document says.

The cost for the treatment of the fictitious spouse was established at $13,000.